Trial Outcomes & Findings for A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes (NCT NCT04118374)
NCT ID: NCT04118374
Last Updated: 2025-10-28
Results Overview
Participants completed both a one-week RCD and a one-week SCD, separated by a three-week washout. After each intervention, we measured insulin sensitivity using a hyperinsulinemic-euglycemic clamp.To express GIR in mg of glucose per kg of fat-free mass per minute (mg/kg FFM/min), we divided the dextrose infusion rate by the fat-free mass determined by DEXA. Insulin sensitivity showed no significant difference between diets. GIR was 8.1 mg/kg FFM/min after the RCD and 8.6 mg/kg FFM/min after the SCD.
COMPLETED
NA
14 participants
week 1 and week 5
2025-10-28
Participant Flow
14 patients were screened for eligibility between November 2021 and March 2024. We recruited adults with type 1 diabetes (age 18-60 years, BMI 18-33 kg/m2, HbA1c 5.9-9.0%) from the Vanderbilt Eskind Diabetes Clinic and community sources in Nashville, TN.
In the full study, 14 participants enrolled and completed the screening visit. Two did not proceed past the run-in period due to scheduling conflicts and inconsistent nutrition logging.
Participant milestones
| Measure |
Standard Carb Diet then Low Carb Diet
Standard Carb Diet: Approximately 50% of caloric intake will come from carbohydrate consumption.
Low Carb Diet: Approximately 25% of caloric intake will come from carbohydrate consumption.
|
Low Carb Diet then Standard Carb Diet
Standard Carb Diet: Approximately 50% of caloric intake will come from carbohydrate consumption.
Low Carb Diet: Approximately 25% of caloric intake will come from carbohydrate consumption.
|
|---|---|---|
|
First Intervention (7 days)
STARTED
|
6
|
6
|
|
First Intervention (7 days)
COMPLETED
|
6
|
6
|
|
First Intervention (7 days)
NOT COMPLETED
|
0
|
0
|
|
Washout Period (21 days)
STARTED
|
6
|
6
|
|
Washout Period (21 days)
COMPLETED
|
6
|
6
|
|
Washout Period (21 days)
NOT COMPLETED
|
0
|
0
|
|
Second Intervention (7 days)
STARTED
|
6
|
6
|
|
Second Intervention (7 days)
COMPLETED
|
6
|
6
|
|
Second Intervention (7 days)
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
Baseline characteristics by cohort
| Measure |
All Study Participants
n=12 Participants
Standard Carb Diet: Approximately 50% of caloric intake will come from carbohydrate consumption.
Low Carb Diet: Approximately 25% of caloric intake will come from carbohydrate consumption.
then all study participants crossed over to
Low Carb Diet: Approximately 25% of caloric intake will come from carbohydrate consumption.
Standard Carb Diet: Approximately 50% of caloric intake will come from carbohydrate consumption.
|
|---|---|
|
Age, Continuous
|
33.9 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
11 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
12 participants
n=5 Participants
|
|
BMI
|
26.5 kg/m^2
n=5 Participants
|
|
Weight
|
75.3 kg
n=5 Participants
|
|
Height
|
1.75 m
n=5 Participants
|
|
Waist-to-hip ratio
|
0.83 ratio
n=5 Participants
|
|
HbA1c
|
54 mmol/mol
n=5 Participants
|
|
Type 1 diabetes duration
|
20.5 years
n=5 Participants
|
|
Systolic blood pressure
|
120 mmHg
n=5 Participants
|
|
Diastolic blood pressure
|
82 mmHg
n=5 Participants
|
|
Heart rate
|
65 bpm
n=5 Participants
|
|
Insulin analog used
Lispro
|
6 Participants
n=5 Participants
|
|
Insulin analog used
Aspart
|
5 Participants
n=5 Participants
|
|
Insulin analog used
Fast-acting insulin aspart
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: week 1 and week 5Population: 12 participants received both interventions in this crossover study and were included in the analysis.
Participants completed both a one-week RCD and a one-week SCD, separated by a three-week washout. After each intervention, we measured insulin sensitivity using a hyperinsulinemic-euglycemic clamp.To express GIR in mg of glucose per kg of fat-free mass per minute (mg/kg FFM/min), we divided the dextrose infusion rate by the fat-free mass determined by DEXA. Insulin sensitivity showed no significant difference between diets. GIR was 8.1 mg/kg FFM/min after the RCD and 8.6 mg/kg FFM/min after the SCD.
Outcome measures
| Measure |
Standard Carb Diet
n=12 Participants
Standard Carb Diet: Approximately 50% of caloric intake will come from carbohydrate consumption.
|
Low Carb Diet
n=12 Participants
Low Carb Diet: Approximately 25% of caloric intake will come from carbohydrate consumption.
|
|---|---|---|
|
Change in Insulin Sensitivity Assessed as Glucose Infusion Rates
|
8.6 mg/kg FFM/min
Interval 7.0 to 11.0
|
8.1 mg/kg FFM/min
Interval 6.7 to 10.1
|
Adverse Events
Standard Carb Diet
Low Carb Diet
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Standard Carb Diet
n=12 participants at risk
Standard Carb Diet: Approximately 50% of caloric intake will come from carbohydrate consumption.
|
Low Carb Diet
n=12 participants at risk
Low Carb Diet: Approximately 25% of caloric intake will come from carbohydrate consumption.
|
|---|---|---|
|
Nervous system disorders
Headache
|
16.7%
2/12 • Number of events 3 • through study completion, an average of 1 year
Participants self-report
|
0.00%
0/12 • through study completion, an average of 1 year
Participants self-report
|
|
Nervous system disorders
Shakiness
|
0.00%
0/12 • through study completion, an average of 1 year
Participants self-report
|
8.3%
1/12 • Number of events 1 • through study completion, an average of 1 year
Participants self-report
|
Additional Information
Justin M Gregory, MD, MSCI
Vanderbilt University Medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place